LykeShares
Chat Trending Shares
Sign up
Login
Sign Up
(current)
Top 10 Trends
Watchlist
Feedback
Advertise With Us
Profile
Home
Search
Top 10 Trends
Watchlist
Advertise
Feedback
Profile
Collegium Pharmaceutical Inc. Chat
+
Link
Image
Poll
A
Lykeshares
2y
Official
$HUT
Who is Asher Genoot? Newly Appointed CEO of HUT 8 Mining
552 Views
1 Like
Reply
S
Lykeshares
2y
Official
$QPM
How Much of QPM Do the Directors Own?
672 Views
1 Like
Reply
M
Lykeshares
2y
Official
$VSR
Who is Michael Walshe? Chief Executive Officer of Voltaic Strategic Resources
492 Views
1 Like
Reply
G
Lykeshares
2y
Official
$TLG
Who is Martin Phillips? The New CEO of Talga Group
794 Views
1 Like
Reply
D
Lykeshares
2y
Official
$VRC
How did Volt Resources' Achieve the US Government Funding Review?
407 Views
1 Like
Reply
F
Lykeshares
2y
Official
$SHN
How did Sunshine Metals Achieve a Significant Increase in the Liontown Resource?
452 Views
1 Like
Reply
C
Lykeshares
2y
Official
$ARR
How did American Rare Earths Increase its Resource Estimates at Halleck Creek?
500 Views
1 Like
Reply
C
Lykeshares
2y
Official
$NHE
Why is the Mbelele Helium Discovery Significant for Noble Helium?
450 Views
1 Like
Reply
S
Lykeshares
2y
Official
$PLS
Why is Pilbara Minerals Growing its Offtake Agreement with Chengxin?
481 Views
1 Like
Reply
M
Lykeshares
2y
Official
$PMT
What are Patriot Battery Metals latest drilling results from Quebec?
495 Views
1 Like
Reply
C
Lykeshares
2y
Official
$PLS
How Much of Pilbara Minerals Do the Directors Own?
643 Views
1 Like
Reply
T
Lykeshares
2y
Official
$ATC
How is Altech advancing in the Development of their Battery Prototypes?
381 Views
1 Like
Reply
A
Lykeshares
2y
Official
$EUR
Why is European Lithium In a Voluntary Suspension?
681 Views
1 Like
Reply
S
Lykeshares
2y
Official
$DEG
What is De Grey Mining's New Ashburton Gold Project?
280 Views
1 Like
Reply
M
Lykeshares
2y
Official
$AZL
What Strategy Is Arizona Lithium Using for Lithium Brine Extraction?
515 Views
1 Like
Reply
Loading…
NASDAQ:COLL — Live Chart, Financials & Chat | Collegium Pharmaceutical Inc.
C
Collegium Pharmaceutical Inc.
NASDAQ:COLL
United States
Revenue: 707m
$0.0/sec
Add to Watchlist
by TradingView